Alzamend Neuro, Inc. (ALZN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD

Add to watchlist

0.6797

-0.0303

(-4.27%)

At close: 03:50PM EST

0.7100

+0.03

(+4.46%)

After hours:

05:56PM EST

Loading interactive chart…

Business Wire
Alzamend Neuro to Present at Sequire Biotechnology Conference
ATLANTA, January 26, 2023--Alzamend Neuro to Present at Sequire Biotechnology Conference on Thursday, February 2, 2023; Highlighting Alzamend’s Achievements This Past Year
Business Wire
Alzamend Neuro Partners With Biorasi to Conduct a First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase I/IIA Clinical Trial
ATLANTA, January 04, 2023--Alzamend Neuro Partners With Biorasi to Conduct First-in-Human, Randomized, Double-Blind Placebo-Controlled Parallel Group Phase I/IIA Clinical Trial
Business Wire
Alzamend Neuro Partners With the Miller School of Medicine, Interdisciplinary Stem Cell Institute at the University of Miami for ALZN002 Phase I/IIA Immunotherapy Vaccine Clinical Trial to Treat Mild to Moderate Dementia of the Alzheimer’s Type
ATLANTA, December 28, 2022--Alzamend Neuro Partners with Miller School of Medicine at the University of Miami for ALZN002 Phase I/IIA Immunotherapy Vaccine Clinical Trial for AD